Get the Stockscreener App
2.43
2.80%
-0.07
After Hours:
2.37
-0.06
-2.47%
Inovio Pharmaceuticals Inc stock is traded at $2.43, with a volume of 2.06M.
It is down -2.80% in the last 24 hours and up +0.00% over the past month.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
See More
Previous Close:
$2.50
Open:
$2.43
24h Volume:
2.06M
Relative Volume:
1.31
Market Cap:
$129.14M
Revenue:
$832.00K
Net Income/Loss:
$-135.12M
P/E Ratio:
-0.399
EPS:
-6.09
Net Cash Flow:
$-124.69M
1W Performance:
-5.81%
1M Performance:
+0.00%
6M Performance:
+26.56%
1Y Performance:
-55.98%
1-Day Range:
$2.41
$2.575
1-Week Range:
$2.29
$2.675
52-Week Range:
$1.30
$5.80
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Name
Inovio Pharmaceuticals Inc
Sector
Industry
Phone
(858) 410-3134
Address
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare INO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.43 | 132.86M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-14-24 | Initiated | Stephens | Overweight |
| Jan-25-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-09-22 | Downgrade | Maxim Group | Buy → Hold |
| Nov-01-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-19-22 | Resumed | RBC Capital Mkts | Sector Perform |
| May-11-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-29-21 | Resumed | Jefferies | Hold |
| Sep-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-24-21 | Initiated | Jefferies | Hold |
| Mar-23-21 | Initiated | BofA Securities | Neutral |
| Feb-12-21 | Initiated | Oppenheimer | Outperform |
| Nov-17-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Nov-10-20 | Upgrade | ROTH Capital | Sell → Neutral |
| Sep-28-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-28-20 | Upgrade | Maxim Group | Hold → Buy |
| Jul-01-20 | Downgrade | Maxim Group | Buy → Hold |
| Jul-01-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Jun-29-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-26-20 | Downgrade | Stifel | Buy → Hold |
| May-21-20 | Initiated | The Benchmark Company | Buy |
| Apr-30-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Mar-13-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-13-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-19-19 | Initiated | ROTH Capital | Buy |
| Feb-15-18 | Reiterated | Maxim Group | Buy |
| Oct-18-17 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-17 | Initiated | Citigroup | Buy |
| Jun-08-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-24-17 | Reiterated | Maxim Group | Buy |
| Mar-16-17 | Upgrade | Maxim Group | Hold → Buy |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
View All
Inovio Pharmaceuticals Inc Stock (INO) Latest News
Inovio Pharmaceuticals (INO) to Release Earnings on Monday - MarketBeat
Can Inovio Pharmaceuticals Inc. stock outperform in 2025 bull marketWeekly Stock Report & Step-by-Step Swing Trade Plans - newser.com
Price momentum metrics for Inovio Pharmaceuticals Inc. explainedJuly 2025 News Drivers & AI Forecast Swing Trade Picks - newser.com
Is Inovio Pharmaceuticals Inc. (GBM) stock a fit for income portfolios2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com
Inovio (INO) Finalizes BLA Submission for INO-3107 - GuruFocus
Can Inovio Pharmaceuticals Inc. (GBM) stock surprise markets with earningsTrade Risk Report & Detailed Earnings Play Alerts - newser.com
Analyzing Inovio Pharmaceuticals Inc. with multi timeframe chartsTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Strategies to average down on Inovio Pharmaceuticals Inc.CEO Change & Weekly Return Optimization Alerts - newser.com
Why Inovio Pharmaceuticals Inc. stock is rated strong buyShare Buyback & Detailed Earnings Play Alerts - newser.com
How to use a screener to detect Inovio Pharmaceuticals Inc. breakouts2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
Why Inovio Pharmaceuticals Inc. stock is a value investor pick2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
How risky is Inovio Pharmaceuticals Inc. stock now2025 Bull vs Bear & Safe Capital Growth Tips - newser.com
INOVIO to Present at Stephens Virtual Biotechnology Conference on November 4 - MyChesCo
How to read the order book for Inovio Pharmaceuticals Inc.Market Sentiment Summary & Smart Investment Allocation Tips - newser.com
What RSI levels show for Inovio Pharmaceuticals Inc. (GBM) stockMarket Rally & Weekly Stock Performance Updates - newser.com
Is Inovio Pharmaceuticals Inc. trending in predictive chart modelsJuly 2025 Macro Moves & High Accuracy Investment Signals - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock expand revenue streams2025 Buyback Activity & Long Hold Capital Preservation Tips - newser.com
Statistical indicators supporting Inovio Pharmaceuticals Inc.’s strengthShare Buyback & Growth Focused Stock Reports - newser.com
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults - PR Newswire
Will Inovio Pharmaceuticals Inc. stock go up soonJuly 2025 Fed Impact & Weekly High Return Opportunities - newser.com
Why hedge funds are buying Inovio Pharmaceuticals Inc. stock2025 Major Catalysts & Verified Momentum Stock Alerts - newser.com
Is Inovio Pharmaceuticals Inc. stock attractive after correctionRecession Risk & Weekly High Return Forecasts - newser.com
INOVIO Reports Inducement Grant under Inducement Plan - MarketScreener
Will breakout in Inovio Pharmaceuticals Inc. lead to full recovery2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
Published on: 2025-11-03 04:28:05 - newser.com
Will Inovio Pharmaceuticals Inc. stock rally after Fed decisionsQuarterly Trade Summary & Verified Entry Point Signals - newser.com
What momentum indicators show for Inovio Pharmaceuticals Inc. stock2025 Key Lessons & Safe Capital Allocation Plans - newser.com
Chart based analysis of Inovio Pharmaceuticals Inc. trendsM&A Rumor & Growth Oriented Trade Recommendations - newser.com
How reliable is Inovio Pharmaceuticals Inc. (GBM) stock dividend growthGap Up & Weekly High Conviction Ideas - newser.com
What hedge fund moves indicate for Inovio Pharmaceuticals Inc. (GBM) stock2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock reach $200 price targetGold Moves & AI Forecast Swing Trade Picks - newser.com
Published on: 2025-11-02 13:43:13 - newser.com
Inovio Pharmaceuticals Inc Stock (INO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):